Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Hawaii Tech Times.
Press releases published on June 20, 2025
Lucas GC Limited Announces Pricing of Follow-On Offering
GlobeNewswire
·
June 20, 2025
NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Lucas GC Limited (NASDAQ: LGCL) (“Lucas” or the “Company”), an artificial intelligence (“AI”) technology-driven Platform-as-a-Service (“PaaS”) company with proprietary technologies applied to the human resources …
Donald De Lucca Joins Advisory Board of Alternative Ballistics Corporation to Enhance Law Enforcement Growth Strategy
GlobeNewswire
·
June 20, 2025
Las Vegas, Nevada, June 20, 2025 (GLOBE NEWSWIRE) -- Alternative Ballistics Corporation, an innovative public safety technology company, is proud to announce that Donald De Lucca, former President of the International Association of Chiefs of Police (IACP) …
ALL4 Mining Commits to Sustainable Cloud Mining Through Renewable-Powered Data Centers
GlobeNewswire
·
June 20, 2025
London, UK, June 20, 2025 (GLOBE NEWSWIRE) -- ALL4 Mining, a rising force in cloud-based cryptocurrency mining, today announced a major sustainability milestone: its transition to renewable-powered data centers. By integrating solar, wind, and …
INVO Fertility Reminds Shareholders to Cast Their Vote for Upcoming Annual Meeting of Shareholders to be held on Wednesday, June 25, 2025 at 12:00 p.m. Eastern Time
GlobeNewswire
·
June 20, 2025
SARASOTA, Fla., June 20, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility focused company, reminds shareholders to vote their shares online ahead of the upcoming annual meeting of …
VERSES® Announces Consolidation of Class A Subordinate Voting Shares
GlobeNewswire
·
June 20, 2025
VANCOUVER, British Columbia, June 20, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSD) ("VERSES'' or the "Company”), a cognitive computing company specializing in next-generation agentic software systems, announces the Company is …
Actuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCO
GlobeNewswire
·
June 20, 2025
CHICAGO and FORT WORTH, Texas, June 20, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult- …
VivoPower Closes First Phase of US$121 Million Private Placement
GlobeNewswire
·
June 20, 2025
LONDON, June 20, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ: VVPR) (“VivoPower” or the “Company”) today announced that it has closed the first phase of the previously announced US$121 million investment round led by His Royal Highness …
ideal-finance.com Partners with International Financial Giants to Build a New Mechanism for Global Asset Cross-Border Circulation
GlobeNewswire
·
June 20, 2025
New York, USA, June 20, 2025 (GLOBE NEWSWIRE) -- The leading global digital finance platform ideal-finance.com has announced deep strategic collaborations with several top international banks and multinational financial institutions to jointly promote the …
Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference
GlobeNewswire
·
June 20, 2025
SCOTTSDALE, Ariz., June 20, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or “our”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and …
ideal-finance.com Achieves Breakthrough in Technical Strength, Establishing a Global Benchmark with Full-Stack Self-Developed Financial System
GlobeNewswire
·
June 20, 2025
New York, USA, June 20, 2025 (GLOBE NEWSWIRE) -- In the context of rapid globalization in fintech, ideal-finance.com has once again set a new industry standard by announcing the full launch of its next-generation trading system, developed entirely in-house …
Martini Market Fills Over 40% of Presale Allocation Within 24 Hours of Launch on XRP Ledger
GlobeNewswire
·
June 20, 2025
DUBAI, United Arab Emirates, June 20, 2025 (GLOBE NEWSWIRE) -- Martini Market, a decentralized prediction market protocol built on the XRP Ledger (XRPL), has announced that over 40% of its $MRT token presale allocation has been filled within the first 24 …
SpringWorks Therapeutics Receives Positive CHMP Opinion for Nirogacestat for the Treatment of Adults with Desmoid Tumors
GlobeNewswire
·
June 20, 2025
– If approved, nirogacestat will be the first and only therapy with marketing authorization in the EU for the treatment of desmoid tumors – – Decision from European Commission expected in the third quarter of 2025 – STAMFORD, Conn., June 20, 2025 (GLOBE …
Bilibili Inc. Announces Results of Annual General Meeting
GlobeNewswire
·
June 20, 2025
SHANGHAI, June 20, 2025 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (Nasdaq: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced that each of the proposed resolutions (the …
Soleno Therapeutics Announces Multiple Presentations at the 2025 United in Hope: International Prader-Willi Syndrome Conference
GlobeNewswire
·
June 20, 2025
REDWOOD CITY, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced one oral and six poster presentations …
BullFrog AI’s Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks Webinar
GlobeNewswire
·
June 20, 2025
GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the …
Telix Precision Medicine Announces AlFluor Radiochemistry Platform
GlobeNewswire
·
June 20, 2025
MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces it has launched a novel PET1 radiochemistry solution based on 18F-aluminium fluoride (AlF …
Aptose and Hanmi Enter New Loan Agreement to Advance Development of Tuspetinib in Triplet Therapy for AML
GlobeNewswire
·
June 20, 2025
SAN DIEGO and TORONTO, June 20, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …
Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer’s Patients
GlobeNewswire
·
June 20, 2025
– Research supports combined use of EEG/ERP and vMRI for accurate differential diagnosis of SCD, MCI and dementia – – Also highlights that low-cost and off-based EEG/ERP alone also delivered reasonably accurate predictions of cognitive impairment typology …
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for QINLOCK® (ripretinib)
GlobeNewswire
·
June 20, 2025
LOUISVILLE, Ky., June 20, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Deciphera Pharmaceuticals, LLC for QINLOCK® (ripretinib), which has been approved by the U.S. Food …
Madrigal Receives Positive CHMP Opinion for Resmetirom (Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
GlobeNewswire
·
June 20, 2025
Positive recommendation based on resmetirom’s favorable profile including positive results from the pivotal Phase 3 MAESTRO-NASH trial European Commission decision expected in August 2025; if approved, resmetirom will be the first medication for people …